Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Funding round 2024

Project funding for prevention in healthcare – dementia

    • Practice Management
    • Prevention and health care
    • RX
  • 2 minute read

As part of the 2024 funding round of project funding for prevention in healthcare (PGV), projects are being sought on the specific topic of “Improving the treatment of dementia along the healthcare pathway”. The Call for Proposals runs until January 19, 2024.

Based on the action plan for the National Strategy for the Prevention of Non-Communicable Diseases (NCD Strategy) 2021-2024, the basic document on prevention in healthcare (PGV) and the PGV 2021-2024 project funding concept, the Swiss Health Promotion Foundation supports projects to strengthen prevention in healthcare. Health Promotion Switzerland supports projects in the areas of non-communicable diseases (NCDs), addiction and mental illness. The aim of all the projects is to establish preventive practices along the health pathways in order to maintain the quality of life and autonomy of people who are ill or at increased risk of illness, to reduce their need for treatment and, as a result, to curb healthcare costs.

The focus of the second implementation phase (2021-2024) of the PGV project funding is on the development priorities of quality, preparation for establishment and communication. In the 2024 funding round, only projects by stakeholders based on calls for proposals on specific topics (funding area III) will be supported. These provide for the implementation of preventive practices of the topic-specific call for proposals “Improving the treatment of dementia along the health pathway”. All project applications are submitted on the online platform Promotion Digitale. The number of projects that can be funded on the basis of this Call for Proposals is very limited and the requirements for project submissions are high. Project evaluation and selection follows a standardized process, and the projects with the highest quality are ultimately selected and supported. The Federal Office of Public Health (FOPH) is involved in the tendering and selection of projects.

The projects should pursue the following main objective

Increased (early) detection of cognitive disorders, slowing their development into dementia by maintaining independence; improving the quality of life of people with dementia or at risk of dementia and their family caregivers by introducing a specific health pathway.

Funding will be provided for around two high-quality projects that develop the systematic integration of preventive practices into the healthcare system within the identified areas with a high need for action. The funding amount per contract is CHF 1-1.5 million over a term of four years.

Source: https://gesundheitsfoerderung.ch/sites/default/files/2023-09/2023-09_Projektfoerderung_PGV_-_Call_for_Proposals_2024.pdf (last accessed on 21.11.2023)

InFo NEUROLOGY & PSYCHIATRY 2023; 21(6): 40 (published on 2.12.23, ahead of print)

Autoren
  • Leoni Burggraf
Publikation
  • InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
  • Dementia
  • Health Promotion
  • Healthcare
  • NCD Strategy
  • Prevention
Previous Article
  • New ESH guideline

Screen hypertensive patients regularly for albuminuria

  • Cardiology
  • General Internal Medicine
  • Nephrology
  • RX
View Post
Next Article
  • Sjögren's syndrome

Algorithm helps with pSS diagnosis

  • Congress Reports
  • General Internal Medicine
  • ORL
  • Rheumatology
  • RX
View Post
You May Also Like
View Post
  • 7 min
  • Pediatric Retinoblastoma

The Tumor Microenvironment and Modern Eye-Sparing Therapies

    • RX
    • Education
    • Oncology
    • Ophthalmology
    • Pediatrics
View Post
  • 3 min
  • Adherence and management in asthma and COPD

Better to listen to the pharmacist

    • RX
    • Education
    • General Internal Medicine
    • Pharmacology and toxicology
    • Pneumology
    • Studies
View Post
  • 14 min
  • Focus Update 2026

Echocardiography in Cardio-Oncology

    • RX
    • Cardiology
    • Education
    • Oncology
    • Radiology
    • Studies
View Post
  • 4 min
  • Physical activity with IBD

Sport is not murder, but it doesn’t help either

    • RX
    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Sports Medicine
    • Studies
View Post
  • 3 min
  • White and Black Skin Cancer

Biology and Modern Therapeutic Approaches

    • RX
    • Dermatology and venereology
    • Education
    • Oncology
    • Prevention and health care
    • Studies
    • Surgery
View Post
  • 5 min
  • Highlights from the AAD Annual Meeting

Atopic Dermatitis: Interesting News on Drug Candidates in Phase III

    • RX
    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Studies
View Post
  • 6 min
  • Autoimmune Liver Diseases

Innovative Treatment Approaches for PBC, PSC, and AIH: What’s New?

    • RX
    • Congress Reports
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Studies
View Post
  • 8 min
  • Myelofibrosis

Mutations and Molecular Diagnostics in Treatment Decisions

    • RX
    • Education
    • Hematology
    • Oncology
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Update on Anti-Rheumatic Medications
  • 2
    Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
  • 3
    Focus on preventive care options
  • 4
    Inflammation as a Treatment Goal in Its Own Right
  • 5
    Personalized Treatment Before a Planned Pregnancy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.